Navigation Links
FDA Clears Software Upgrade for Fenwal Plasma-Collection System
Date:8/19/2010

LAKE ZURICH, Ill., Aug. 19 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market a new software release for its Autopheresis-C® system.  Blood and plasma centers worldwide use the Autopheresis-C system to collect plasma from donors.

The new software includes many new features designed to improve plasma collection for plasma- and blood-center professionals and donors.  The software helps automate and streamline collection processes, which reduce the need for operator intervention and help to improve work flow and reduce procedure times.  New confirmatory prompts are designed to make accurate programming for target plasma volumes even easier.

"The Autopheresis-C® system has long been an industry standard for collecting plasma of exceptional quality," said William H. Cork, chief technology officer for Fenwal.  "Our customers can now expect a series of innovations from Fenwal designed to make great instruments even better in terms of speed, ease of use and communications with plasma center information systems."

Plasma is the liquid portion of blood that contains valuable proteins used to treat burn victims, bleeding disorders, and for several therapeutic applications under development, such as for Alzheimer's disease, heart disease, and some cancers.  Plasma-derived proteins have become integral to many novel medical therapies in late-stage development.  Fenwal has established technical partnerships with pharmaceutical companies to assist them in this research and development.

About Fenwal

Fenwal, Inc. is a global medical technology company focused on improving blood collection, filtration, separation, storage and transfusion to ensure the availability, safety and effectiveness of blood components.  Fenwal is unique in the depth of its experience and commitment to transfusion medicine.  The company offers the broadest range of products for the automated and manual collection of blood and blood components.  Fenwal became an independent company in 2007, but its roots go back to 1949 with the founding of Fenwal Laboratories.  Fenwal developed the first flexible, single-use container for blood collection, eliminating complications associated with glass containers and allowing blood to be separated into therapeutic components.  Today, the company's products and advanced collection and separation technologies are used to help treat patients on six continents.  Fenwal, Inc. is based in Lake Zurich, Illinois.  For more information, please visit www.fenwalinc.com.


'/>"/>
SOURCE Fenwal, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Clears AirStrip RPM for CRITICAL CARE & CARDIOLOGY Remote Patient Monitoring Solutions
2. FDA Clears Xlumenas NAVIX(TM) Access Device
3. FDA Clears Three Additional Antimicrobials for Use on TREK Sensititre(R) In Vitro Diagnostic (IVD) MIC Susceptibility Plates: Minocycline and Telavancin Used to Treat MRSA and Other Infections; and Tigecycline, Now Cleared for Streptococcus Pneumoni
4. FDA Clears the Fenwal Amicus(R) Separator System for Collecting Platelets in New Additive Solution
5. FDA Grants Cequent IND - Clears Way for First-Ever Clinical Trial of Orally Delivered RNAi Therapeutic: CEQ508, a tkRNAi Drug Candidate in Oncology
6. FDA Clears the First Rapid Test to Detect Bacteria in Pooled Platelets
7. U.S. Food and Drug Administration Clears Alcatel-Lucent Remote Patient Monitoring Solution for Sale in the United States
8. Private Investment Firm Czura Thornton Today Introduces Clearstone Central Laboratories as the Newest Member of the Czura Thornton Life Science Group
9. FDA Clears a Test for Ovarian Cancer
10. U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies SUPERA Peripheral Stent
11. FDA Clears the Pathwork(R) Tissue of Origin Test for Hard-To-Identify Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Pharmacy, Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, ...  All comparisons, unless otherwise noted, are to the quarter ended ... Second Quarter 2017 Highlights include: Revenue ... 3.5% Total prescriptions dispensed of 220,000, compared ... 7.6% Gross profit per prescription dispensed ...
(Date:8/2/2017)... , Aug. 2, 2017 ... Who,s Who as a Pinnacle Lifetime Professional in ... Key Account Manager at Turing Pharmaceuticals, AG. Her ... troubleshooting and relationship building.                ... more than 25 years of experience as a ...
(Date:7/31/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named ... by Crain,s Detroit Business . ... by three-year revenue growth. This year,s edition measures growth from ... view the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... triumph," said Phil Hagerman , CEO and chairman of ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... ... LabRoots , the leading provider of educational and interactive virtual events ... Andrew Ly as the winner of the LabRoots Summer Textbook scholarship, awarding him $1000 ... is in his third year at the University of California, Los Angeles majoring in ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... the endoscope after every reprocessing cycle, both between patient procedures and before storage, ... infections. Drying is as important to the prevention of disease transmission and nosocomial ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... company based in Vero Beach, announced today that two of their associates were ... that represents professionally managed senior living communities in Florida. The awards were announced ...
(Date:8/16/2017)... ... , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating to Test Country, ... the United States has undergone major changes over the last decade, particularly when it ... order to get a blood test or other lab work done. Today, most tests ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence ... pelvic pain. In addition to oncology services, the new center will specialize ... (abnormal heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar ...
Breaking Medicine News(10 mins):